Physician profile
Michael Shorofsky
NPI 1689089682
$10,569.93
in general payments reported to CMS, 2019-2025
8 companies · $3,077 in 2025
The $3,077 reported for 2025 was more than what 89% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,406 · 2022: $301 · 2023: $3,421 · 2024: $2,365 · 2025: $3,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,085 · Food and Beverage: $3,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,084.77 |
| Food and Beverage | $3,778.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,479.83 | 2021-2025 | Harmony |
| Abbott Laboratories | $1,465.96 | 2021-2025 | Amplatzer Piccolo, Amplatzer |
| W. L. Gore & Associates, INC. | $1,083.94 | 2021-2025 | Gore Cardioform Septal Occluder |
| Renata Medical, INC. | $264.01 | 2025 | Minima Stent System - 8mm, Minima Stent System - 6mm |
| Numed For Children, LLC | $157.43 | 2021 | |
| Edwards Lifesciences Corporation | $73.16 | 2021-2022 | |
| Terumo Medical Corporation | $29.47 | 2022 | |
| B. Braun Interventional Systems INC. | $16.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shorofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.